Is prematurity a risk factor for developmental dysplasia of the hip? : a prospective study

M M Orak1, T Onay2, S A Gümüştaş3

  • 1Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey.

Insights

Prematurity is not a risk factor for developmental dysplasia of the hip (DDH). This study found no significant difference in hip dysplasia incidence between preterm and full-term infants, suggesting prematurity does not predispose infants to DDH.

Area of Science:

  • Pediatrics
  • Orthopedic Surgery
  • Neonatology

Background:

  • Developmental dysplasia of the hip (DDH) is a common condition affecting infants.
  • Prematurity is a potential risk factor for various infant health issues, but its role in DDH is debated.

Purpose of the Study:

  • To investigate whether prematurity is a risk factor for developmental dysplasia of the hip (DDH).

Main Methods:

  • A prospective study compared 221 preterm infants (born ≤34 weeks gestation) with 246 full-term infants.
  • Infants were assessed using physical examination (Ortolani's, Barlow's tests) and Graf ultrasound within one week of corrected age.
  • Both hips of all infants were evaluated for signs of dysplasia.

Main Results:

  • A statistically significant difference was observed in the incidence of mature and immature hips between preterm and full-term infants (p < 0.001).
  • The proportion of infants with an alpha angle < 60° differed significantly (p < 0.001).
  • However, the incidence of pathological dysplasia (alpha angle < 50°) was not significantly different between the groups (p = 1.000), with Barlow sign present in 0.5% of preterm and 2.8% of full-term infants.

Conclusions:

  • Prematurity is not a predisposing factor for developmental dysplasia of the hip (DDH).
  • The study suggests that other factors, not prematurity itself, may be more influential in the development of DDH.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.6K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
41
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.6K
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...
47.6K